My ePortfolio Register   

ESMO 2017 /
Expert commentary on melanoma immunotherapy latest

8th - 12th Sep 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.09.17
Views: 685
Rating:

Dr Jeffrey Weber, Dr Axel Hauschild, Dr Dummer Reinhard

Dr Jeffrey Weber (Perlmutter Cancer Center, New York, USA), Dr Axel Hauschild (University Hospital, Schleswig-Holstein, Germany) and Dr Dummer Reinhard (University of Zurich, Zurich, Switzerland) comment on three trials looking into treating patients with advanced melanoma, in a press conference at the ESMO 2017 Congress

For more on the COMBI-AD trial watch the press conference or Dr Hauschild spoke with ecancer here

For more on the Checkmate 238 trail watch the press conference or Dr Weber spoke with ecancer here

Dr Karl Lewis also presented data from the BRIM8 trial of adjuvant vemurafenib in BRAFV600 melanoma at the press conference, and spoke with ecancer here

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence